Changsha Suiyilary E-commerce Co., LTD – Trademark Portfolio

Entity Type: 99

Changsha Suiyilary E-commerce Co., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SUIYILARY. The owner is based in Changsha City, Hunan.

No.238 North Liujiachong Rd,Tianxin Dist

Rm 601-580,Phase III,MantingFangjiayuan

Changsha City, Hunan 410000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SUIYILARY
SUIYILARY
Registered 2024

Trademark Classifications

Changsha Suiyilary E-commerce Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Changsha Suiyilary E-commerce Co., LTD have?

Changsha Suiyilary E-commerce Co., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changsha Suiyilary E-commerce Co., LTD file in?

Changsha Suiyilary E-commerce Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Changsha Suiyilary E-commerce Co., LTD's most well-known trademarks?

Changsha Suiyilary E-commerce Co., LTD's registered trademark portfolio includes well-known marks such as SUIYILARY. These are among 1 currently registered trademark in the portfolio.

What is Changsha Suiyilary E-commerce Co., LTD's trademark registration success rate?

Changsha Suiyilary E-commerce Co., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.